20.05.2026, 20:55

Kazakhstan's PollenVax vaccine for wormwood allergy could reach market by 2030-2032

ASTANA. May 20 (Interfax-Kazakhstan) - Kazakh scientists are developing what they say is the world's first recombinant allergy vaccine, PollenVax, against wormwood pollen, with the vaccine potentially reaching the market by 2030-2032, the National Agriculture Scientific and Educational Center said.

To read the full news articles, Subscribe.

01:50PM
KazTransOil to raise several oil export tariffs from July 1

01:44PM
Rail shipments of Tengiz crude drop 8% in 2025 - KTZ

11:48AM
Kazakhstan to break ground on 'Data Center Valley' in June 2026

11:43AM
Putin to make state visit to Kazakhstan May 27-29

11:34AM
Issue 601 of Kazakhstan Mining Report highlights recent sector developments

10:38AM
Kazakhstan approves 32.5 billion tenge biopharmaceutical plant in Alatau SEZ

09:38AM
Kazakhstan to inspect addiction treatment centers after driver testing complaints

09:27AM
KTZ still targets 2026 IPO despite talk of delay

09:16AM
Kazakh businessman acquires 39.3% stake in ERG from founders

08:59AM
Kazakhstan to stage fighter jet flyover above capital on May 28 - Ministry

08:48AM
Kazakhstan drafts legal framework for air taxis, plans 6 vertiports by 2028